Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Identify dividend ETFs with the cheapest expense ratios without sacrificing reliability. This guide helps distinguish leaders in low-cost access.
27,552 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Wall Street chatter about a SpaceX and Tesla merger has sparked a wave of questions. This article unpacks what the ph...
Three stocks in an overlooked sector are gaining attention in 2026 as AI and data-center demand drive automation and ...
Boeing stands at greater risk than peers if Elon Musk's Tesla and SpaceX ever join forces, a scenario analysts say co...
As AI investment surges, the real cash flow winners are the hardware and infrastructure suppliers. Analysts say forge...
A keynote from Nvidia's founder signals a major shift for AI hardware and software. This could change the game for Nv...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...
U.S. equities drift modestly lower as traders await Federal Reserve cues and key data. This stock market live july br...
Investors are flocking to renewable energy stocks as policy support and expanding clean-energy projects push the sect...
Chevron stock climbs as crude prices rise, stoking debate on how high it can go this year. Analysts point to Hess syn...
If you missed Nvidia's historic run, you're not out of luck. This article outlines two solid AI-focused winners at di...
The latest CBO outlook warns the OASI trust fund could run dry by 2032 if reforms stall, signaling potential changes ...